farnesoid X receptor antagonists (GlaxoSmithKline)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namefarnesoid X receptor antagonists (GlaxoSmithKline)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR antagonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsMetabolic DiseasesLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesLiver Diseases

Other Information

ATC CodeN/A
Related LinksN/A